Research

Another non-opioid option besides nerve blocks works better for patients recovering from knee replacement surgery, according to a study by Andrew Shinar, M.D., associate professor of Orthopaedic Surgery and Rehabilitation. Read More

Vanderbilt University has been awarded a major federal grant — $16 million over four years — to coordinate AIDS education and training efforts in Tennessee and seven other southeastern states. Read More

Buddy Creech, M.D., MPH, associate professor of Pediatrics, has been named director of the Vanderbilt Vaccine Research Program (VVRP) in the Division of Pediatric Infectious Diseases. Read More

For more than twenty years, Vanderbilt-Ingram Cancer Center’s (VICC) primary source of outside funding has been provided by the National Institutes of Health. But in breast cancer, Susan G. Komen, a nonprofit dedicated to breast cancer research and community services, has been a significant sponsor of research and patient care support. Read More

The first study to suggest that major depressive disorder (MDD) is an independent risk factor for heart failure in HIV-positive adults has been published in Circulation. Read More

Lymphedema patients saw a nearly 80 percent reduction in cellulitis episodes by using an advanced pneumatic compression device at home, according to a study in JAMA Dermatology co-authored by Vanderbilt University School of Nursing’s Sheila Ridner, Ph.D., and University of Minnesota School of Public Health Associate Professor Pinar Karaca-Mandic, Ph.D. Read More

When faced with ambiguous visual information, it is the visual processing areas of the brain that choose between the competing impressions, not the higher levels of the brain as previously thought. Read More

A majority of Guatemalans believe it is understandable, and sometimes even acceptable, for women who cheat on their husbands to be subjected to violence in return, the results of a new survey indicate. Read More

Structural and molecular details of an anti-fungal target's interaction with inhibitors suggest ways to design better treatments for fungal infections. Read More

More than half of hospitalizations due to influenza pneumonia could be prevented by influenza vaccination, according to a study led by investigators at Vanderbilt University Medical Center, published this week in the Journal of the American Medical Association. Read More

The glutamine transporter protein appears to contribute to the survival of lung cancer cells, suggesting it may be a useful diagnostic biomarker and target for therapies. Read More

Recent experiments at the world's largest atom smashers are producing liquid drops so small that they raise the question of how small a droplet can be and still remain a liquid. Read More

The U.S. federal government is preparing to launch a set of sweeping new regulations that will have a major impact on how biomedical researchers and social scientists work. It will require researchers to change how they get ethics approval, how they collect informed consent from participants, and more. Read More

New findings add to the understanding of how the enzyme COX-2 works, which is critical to the development of COX-2-targeted anti-inflammatory drugs. Read More

Mark Hatch, CEO and co-founder of TechShop, a fast-growing chain of co-working spaces where people come to build prototypes for the products they want to sell, is giving a free public lecture on the Maker Revolution. Read More

Two innovative but very different products designed by Vanderbilt University engineers are getting a financial push onto the market, thanks to National Science Foundation Accelerating Innovation Research–Technology Translation (AIR-TT) grants of about $200,000 each. Read More

Vanderbilt University has received a contract from the Centers for Medicare and Medicaid Services (CMS) for up to $28 million over four years to help more than 4,000 clinicians in the Southeast transform their clinical practices in ways that improve quality of patient care and hold down costs. Read More

La Jolla Pharmaceutical Co. and Vanderbilt University have signed a research and license agreement covering Vanderbilt’s research program and intellectual property rights related to compounds that block bone morphogenetic protein (BMP) type-I receptors. The compounds have therapeutic potential in a broad range of diseases, including rare genetic disorders. Read More

A new genetic model has generated new strategies for promoting tolerance to transplants – and improving long-term transplant outcomes – in the background of autoimmune disease. Read More

Declining use of prescription painkillers among preoperative patients seeking joint replacements indicates efforts by the state of Tennessee to tighten the spigot on opioids are beginning to have an impact, according to a study by Vanderbilt’s Andrew Shinar, M.D. Read More